Heart Failure: Mechanisms and Therapies
joint with Mitochondria, Metabolism and Heart
Scientific Organizers: David A. Kass and Saptarsi M. Haldar
Date: February 26 - March 01, 2022
|InPerson Location: Beaver Run Conference Center, Breckenridge, CO, USA|
|Meeting is available as a Livestream, click register button below for more details|
|Meeting is available to view On Demand, click register button below for more details|
For Updated Health and Safety Guidelines for Keystone Symposia in-person meetings, click here
The COVID-19 pandemic put the kibosh on our originally planned 2021 HF meeting, as we felt this meeting is really best done in person, we decided to wait a year and try again. The Keystone meetings are being shortened by 25% - 3 days instead of 4, so adjustments to the program have been made. Importantly, even one year later, heart failure (HF) is still a leading global cause of morbidity and mortality. As life expectancy increases, individuals are experiencing the compounded effects of accumulated disease, genetic propensity, environmental stress, and behavior. The underpinnings of HF are multifactorial, providing a broad array of relevant biochemical therapeutic targets that could impact clinical symptoms and outcomes. Aging, the obesity epidemic and associated disorders, such as diabetes, have a major impact on heart failure pathophysiology. The roles of altered metabolism, mitochondrial dysfunction, protein quality control, inflammation, and fibrosis as well as the latest methods for single-cell analysis of subpopulations studies on epigenetic control of disease and heart development/regeneration will be featured. The dawn of a new age in manipulation of heart contractions is upon us and this conference will enable discussion of recent advances in HF treatment, including clinical testing. Many of the speakers are leaders in highly relevant fields that are not always featured at typical HF conferences. One of our goals is to encourage dialog and foster interdisciplinary collaboration between researchers in fields that are all relevant to the failing heart. Lastly, this conference is being paired with another Keystone Symposia conference on Mitochondria, Metabolism and Heart, which will also have a cardiac emphasis. There will be two joint sessions that will focus on mitochondrial function and metabolism, respectively.
Global Health Award Deadline: February 7 2022 details
Scholarship Deadline: November 16 2021 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.
All those submitting an abstract should plan to attend in-person to ensure extensive interaction opportunities. At this time we recognize that a small percentage of submitters may be unable to travel due to border crossing restrictions and/or institutional travel bans. If these restrictions are still in place during the meeting, permissions for remote presentations will be given for the exceptional circumstances listed above.
NOTE: In the event that your abstract isn't selected for a short talk and you're not able to travel the abstract fee is nonrefundable. All paid abstracts will be included in the meeting app and meeting materials available online.
We gratefully acknowledge the generous grant for this conference provided by:National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1R13HL154588-01
Funding for this conference was made possible (in part) by 1R13HL154588-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.